ABT-387/r early access program expanded further.
D019380:Anti-HIV Agents / Q000600:supply & distribution* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000600:supply & distribution* / Q000627:therapeutic use; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000600:supply & distribution* / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir